Cargando…
Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis
Non-alcoholic fatty liver disease (NAFLD) is a disease characterized by a steatosis of the liver that may progress to more serious pathological conditions including: nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. As the prevalence of NAFLD has increased worldwide in recent years, path...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701750/ https://www.ncbi.nlm.nih.gov/pubmed/29177105 http://dx.doi.org/10.4172/2155-9899.1000523 |
_version_ | 1783281399704322048 |
---|---|
author | Sharma, Dana L. Lakhani, Hari Vishal Klug, Rebecca L. Snoad, Brian El-Hamdani, Rawan Shapiro, Joseph I. Sodhi, Komal |
author_facet | Sharma, Dana L. Lakhani, Hari Vishal Klug, Rebecca L. Snoad, Brian El-Hamdani, Rawan Shapiro, Joseph I. Sodhi, Komal |
author_sort | Sharma, Dana L. |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) is a disease characterized by a steatosis of the liver that may progress to more serious pathological conditions including: nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. As the prevalence of NAFLD has increased worldwide in recent years, pathophysiology and risk factors associated with disease progression of NAFLD are at the focus of many studies. NAFLD is related to and shares common serum biomarkers with cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), obesity, and metabolic syndrome (MetS). West Virginia (WV) is a state with some of the highest rates of CVD, obesity and diabetes mellitus. As NAFLD is closely related to these diseases, it is of particular interest in WV. Currently there is no cost-effective, standardized method used clinically to detect NAFLD prior to the onset of reversible complications. At this time, the diagnosis of NAFLD is made with costly radiologic studies and invasive biopsy. These studies are only diagnostic once changes to hepatic tissue have occurred. The diagnosis of NAFLD by traditional methods may not allow for successful intervention and may not be readily available in areas with already sparse medical resources. In this literature review, we identify a list of biomarkers common among CVD, T2DM, obesity, MetS and NAFLD. From this research we propose the following biomarkers are good candidates for inclusion in a panel of biomarkers for the early detection of NAFLD: adiponectin, AST, ALT, apo-B, CK18, CPS1, CRP, FABP-1, ferritin, GGT, GRP78, HDL-C, IGF-1, IL-1β, 6, 8, 10, IRS-2PAI-1, leptin, lumican, MDA SREBP-1c and TNF-α. Creating and implementing a biomarker panel for the early detection and attenuation of NAFLD, prior to the onset of irreversible complication would provide maximum benefit and decrease the disease burden on the patients and healthcare system of WV. |
format | Online Article Text |
id | pubmed-5701750 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
record_format | MEDLINE/PubMed |
spelling | pubmed-57017502017-11-24 Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis Sharma, Dana L. Lakhani, Hari Vishal Klug, Rebecca L. Snoad, Brian El-Hamdani, Rawan Shapiro, Joseph I. Sodhi, Komal J Clin Cell Immunol Article Non-alcoholic fatty liver disease (NAFLD) is a disease characterized by a steatosis of the liver that may progress to more serious pathological conditions including: nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. As the prevalence of NAFLD has increased worldwide in recent years, pathophysiology and risk factors associated with disease progression of NAFLD are at the focus of many studies. NAFLD is related to and shares common serum biomarkers with cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), obesity, and metabolic syndrome (MetS). West Virginia (WV) is a state with some of the highest rates of CVD, obesity and diabetes mellitus. As NAFLD is closely related to these diseases, it is of particular interest in WV. Currently there is no cost-effective, standardized method used clinically to detect NAFLD prior to the onset of reversible complications. At this time, the diagnosis of NAFLD is made with costly radiologic studies and invasive biopsy. These studies are only diagnostic once changes to hepatic tissue have occurred. The diagnosis of NAFLD by traditional methods may not allow for successful intervention and may not be readily available in areas with already sparse medical resources. In this literature review, we identify a list of biomarkers common among CVD, T2DM, obesity, MetS and NAFLD. From this research we propose the following biomarkers are good candidates for inclusion in a panel of biomarkers for the early detection of NAFLD: adiponectin, AST, ALT, apo-B, CK18, CPS1, CRP, FABP-1, ferritin, GGT, GRP78, HDL-C, IGF-1, IL-1β, 6, 8, 10, IRS-2PAI-1, leptin, lumican, MDA SREBP-1c and TNF-α. Creating and implementing a biomarker panel for the early detection and attenuation of NAFLD, prior to the onset of irreversible complication would provide maximum benefit and decrease the disease burden on the patients and healthcare system of WV. 2017-09-29 2017-10 /pmc/articles/PMC5701750/ /pubmed/29177105 http://dx.doi.org/10.4172/2155-9899.1000523 Text en http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Article Sharma, Dana L. Lakhani, Hari Vishal Klug, Rebecca L. Snoad, Brian El-Hamdani, Rawan Shapiro, Joseph I. Sodhi, Komal Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis |
title | Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis |
title_full | Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis |
title_fullStr | Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis |
title_full_unstemmed | Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis |
title_short | Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis |
title_sort | investigating molecular connections of non-alcoholic fatty liver disease with associated pathological conditions in west virginia for biomarker analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701750/ https://www.ncbi.nlm.nih.gov/pubmed/29177105 http://dx.doi.org/10.4172/2155-9899.1000523 |
work_keys_str_mv | AT sharmadanal investigatingmolecularconnectionsofnonalcoholicfattyliverdiseasewithassociatedpathologicalconditionsinwestvirginiaforbiomarkeranalysis AT lakhaniharivishal investigatingmolecularconnectionsofnonalcoholicfattyliverdiseasewithassociatedpathologicalconditionsinwestvirginiaforbiomarkeranalysis AT klugrebeccal investigatingmolecularconnectionsofnonalcoholicfattyliverdiseasewithassociatedpathologicalconditionsinwestvirginiaforbiomarkeranalysis AT snoadbrian investigatingmolecularconnectionsofnonalcoholicfattyliverdiseasewithassociatedpathologicalconditionsinwestvirginiaforbiomarkeranalysis AT elhamdanirawan investigatingmolecularconnectionsofnonalcoholicfattyliverdiseasewithassociatedpathologicalconditionsinwestvirginiaforbiomarkeranalysis AT shapirojosephi investigatingmolecularconnectionsofnonalcoholicfattyliverdiseasewithassociatedpathologicalconditionsinwestvirginiaforbiomarkeranalysis AT sodhikomal investigatingmolecularconnectionsofnonalcoholicfattyliverdiseasewithassociatedpathologicalconditionsinwestvirginiaforbiomarkeranalysis |